FDA — authorised 4 April 1997
- Marketing authorisation holder: VIIV HLTHCARE
- Status: approved
🇺🇸 Rescriptor in United States
FDA authorised Rescriptor on 4 April 1997
Marketing authorisation
Rescriptor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Rescriptor approved in United States?
Yes. FDA authorised it on 4 April 1997.
Who is the marketing authorisation holder for Rescriptor in United States?
VIIV HLTHCARE holds the US marketing authorisation.